Viewing Study NCT00673504


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2026-01-13 @ 12:38 PM
Study NCT ID: NCT00673504
Status: COMPLETED
Last Update Posted: 2011-12-01
First Post: 2008-05-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer
Sponsor: Central European Society for Anticancer Drug Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None pancreatic cancer View
None gemcitabine View
None sunitinib View
None Phase 2 View